Nordic walking for cardiovascular prevention in patients with ischaemic heart disease or metabolic syndrome

被引:4
|
作者
Vehi, Cristina [1 ]
Falces, Carles [1 ]
Angel Sarlat, Miquel [2 ]
Gonzalo, Ana [3 ]
Andrea, Rut [1 ]
Sitges, Marta [1 ]
机构
[1] Univ Barcelona, Inst Cardiovasc, Hosp Clin, Serv Cardiol, Barcelona, Spain
[2] Ctr Atencio Primaria Bordeta Magoria, Inst Catala Salut, Barcelona, Spain
[3] Ctr Atencio Primaria La Marina, Inst Catala Salut, Barcelona, Spain
来源
MEDICINA CLINICA | 2016年 / 147卷 / 12期
关键词
Nordic walking; Ischaemic heart disease; Prevention; Rehabilitation; SECONDARY PREVENTION; PHYSICAL-ACTIVITY;
D O I
10.1016/j.medcli.2016.09.041
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objective: The incidence of atherosclerotic diseases has increased in Europe due in part to the population's sedentary lifestyle. Physical activity is useful for cardiovascular prevention. Nordic walking (NW) mobilizes a great number of muscular groups and is very popular in northern Europe. There is no data available on its impact in the healthcare system of the Mediterranean area. We propose the implementation of a NW program to promote physical activity and control cardiovascular risk factors (CVRF), as well as to improve quality of life and the adherence to medical treatment in patients with a chronic ischemic heart disease or metabolic syndrome. Methods: We selected patients with uncontrolled CVRFs. These patients performed 2 weekly sessions of NW over the course of one year. Baseline data extracted from the patients' medical history, quality of life questionnaires and on adherence to treatment was compared with the results obtained at the end of the program. Results:. A reduction in the rate of CVRFs from 4.78 to 3 was observed, with an evident trend towards the improvement of the patients' quality of life and a better adherence to the treatment. Conclusions: The implementation of a NW program is feasible in the public healthcare system and can aid in the management of CVRFs. (C) 2016 Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:537 / 539
页数:3
相关论文
共 50 条
  • [21] Medications for the secondary prevention of ischaemic heart disease and heart failure are underutilized in dialysis patients
    Ranchord, A. M.
    Harding, S. A.
    Pidgeon, G.
    INTERNAL MEDICINE JOURNAL, 2008, 38 (05) : 361 - U6
  • [22] The rationale of metabolic treatment in ischaemic heart disease
    Marzilli, Mario
    Focardi, Marta
    Affinito, Silvia
    Capati, Eugenia
    Urselli, Rossella
    ARCHIVES OF MEDICAL SCIENCE, 2007, 3 (3A): : S25 - S29
  • [23] PREVENTION OF ISCHAEMIC HEART DISEASE - A UNIQUE EXPERIMENT
    不详
    WHO CHRONICLE, 1969, 23 (05) : 238 - &
  • [24] Predicting the effect of prevention of ischaemic heart disease
    Bronnum-Hansen, H
    SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2002, 30 (01) : 5 - 11
  • [25] Primary dietetic prevention of ischaemic heart disease
    Chanu, B
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 2003, 96 : 21 - 25
  • [26] CURRENT ATTEMPTS AT PREVENTION OF ISCHAEMIC HEART DISEASE
    SHARLAND, DE
    GERONTOLOGIA CLINICA, 1971, 13 (1-2): : 82 - &
  • [27] The interrelationships between lipid metabolism, body mass index and glucose in patients with ischaemic heart disease and metabolic syndrome
    Matveeva, SA
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 173A - 174A
  • [29] INFLAMMATION MARKERS IN PATIENTS WITH CARDIOVASCULAR DISEASE AND METABOLIC SYNDROME
    Korita, Irena
    Bulo, Anyla
    Langlois, Michel
    Blaton, Victor
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2013, 32 (03) : 214 - 219
  • [30] Metabolic syndrome and estimates of cardiovascular disease in cirrhotic patients
    Chavez-Tapia, Norberto C.
    Tellez-Avila, Felix I.
    Valdes-Escarcega, Marisol
    Montano-Reyes, Maria A.
    Ramos, Martha H.
    Lizardi-Cervera, Javier
    Uribe, Misael
    JOURNAL OF DIGESTIVE DISEASES, 2008, 9 (03) : 149 - 155